It is important to note that UK product information for weight management GLP-1 agonists (Wegovy and Saxenda) does include warnings to monitor patients for depression or suicidal thoughts, despite no established causal link
Following the announcement at the beginning of 2023 that Pfizer would terminate the clinical development of another small molecule agonist, Lotiglipron (PF-07081532), the company's suspension of the Phase 3 clinical trial plan for Danuglipron this time has further exacerbated the situation for the company in the type 2 diabetes and obesity market represented by GLP-1R agonists
Every batch is third-party tested to ensure purity and efficacy, so you can trust in the quality and effectiveness of each capsule
Many patients wonder about semaglutide and high blood pressure, particularly whether this medication increases cardiovascular risk
The Bureau of Labor Statistics projects 6% employment growth for dietitians and nutritionists from 2024 to 2034, faster than the average for all occupations
Patients with type 2 diabetes face extra challenges in managing glucose levels when they drink often
